| Trial ID: | L7247 |
| Source ID: | NCT02084251
|
| Associated Drug: |
Pb-119
|
| Title: |
Clinical Trial for PB-119 in Healthy Subjects (Phase I)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type II Diabetes
|
| Interventions: |
DRUG: PB-119
|
| Outcome Measures: |
Primary: Safety/Adverse Event Outcome Measure, Up to 3 weeks |
|
| Sponsor/Collaborators: |
Sponsor: PegBio Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
70
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-02
|
| Completion Date: |
2014-11
|
| Results First Posted: |
|
| Last Update Posted: |
2017-02-14
|
| Locations: |
Peking University First Hospital, Beijing, Beijing, 100000, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02084251
|
